Skip to content
Assyro AI
510(k) Predicate Database
FDA 510(k) ClearanceFPA

NP Medical nPulse K150 Neutral Displacement Needle Free Connector, nPulse Neutral displacement needle free connector, nPulse K150 Needle Free Connector

FDA 510(k) K220288 · Np Medical, Inc.

510(k) number
K220288
Device name
NP Medical nPulse K150 Neutral Displacement Needle Free Connector, nPulse Neutral displacement needle free connector, nPulse K150 Needle Free Connector
Applicant
Np Medical, Inc.
Product code
FPA
Decision
Substantially Equivalent
Decision date
Device class
Class 2
Regulation number
880.5440
Advisory committee
HO
Medical specialty
General Hospital

Candidate predicate devices

Other devices cleared under product code FPA form a screening cohort, not a predicate determination. Compare intended use, technological characteristics, performance evidence, labeling, and current legal-marketing status before selecting a predicate.

Candidate predicate devices for K220288
510(k)DeviceApplicantDecision date
K261530iiSure Infusion SetDeka Research and Development
K252543AMSafe Administration Set (BA-70075, BA-70071-D, BA-70070, BA-70071-P, BA-70072, BA-70072-F, BA-70071-DF, BA-70071-DF-120, FE01, FE04)Amsino International, Inc.
K251375PuraCath Firefly Needleless Connector IT (9005)Puracath Medical, Inc.
K251257nSet+ Stabilization Set [6426733]; nSet+ Stabilization Set with nSyte Needle Free Connector (NFC) [6426731]; nSyte Needle Free Connector (NFC) [6426727]Np Medical
K250325BD Alaris Pump Infusion SetCarefusion (Bd)
K251814EZ™ IV Administration SetEpic Medical Pte. , Ltd.
K251854SteadiSet infusion setTandem Diabetes Care
K243841Sparta Infusion Set for InsulinDeka Research and Development
K243392Infusomat® Space Volumetric Infusion Pump Administration SetsB.Braun Medical, Inc.
K250616Clave™ Neutral-Displacement Needlefree ConnectorsIcu Medical, Inc.
K242692SteadiSet Infusion SetCapillary Biomedical, LLC
K242763JetCan® Pro Safety Huber NeedlePfm Medical, Inc.

Building a 510(k) around this device type?

Assyro turns predicate research into a substantial-equivalence comparison and an eSTAR-ready 510(k) workflow — so predicate strategy, testing evidence, and labeling stay aligned before FDA review.